You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Obsessive-Compulsive Disorder (OCD)
We want to ensure that your Reclaim® DBS Therapy for OCD continues without interruption. Before your battery runs out, you’ll need to replace the neurostimulator of your Reclaim™ DBS system through a surgical procedure. The DBS leads and extensions can typically stay in place and be reconnected to the new neurostimulator(s).
Battery life depends on how much stimulation your device is programmed to provide each day.
Your clinician will closely monitor the performance and battery levels of your neurostimulator at each of your appointments. If you start to show signs of increased OCD symptoms it could be an indication that your Reclaim DBS system isn’t working properly.
Be sure to tell your clinician right away if you experience any unusual symptoms, side effects, or changes in your condition.
Indications: The Medtronic Reclaim™ DBS Therapy is indicated for bilateral stimulation of the anterior limb of the internal capsule, AIC, as an adjunct to medications and as an alternative to anterior capsulotomy for treatment of chronic, severe, treatment-resistant obsessive compulsive disorder (OCD) inadult patients who have failed at least three selective serotonin reuptake inhibitors (SSRIs).
Reclaim DBS Therapy for OCD is available in a very limited number of centres. Only a specialised multidisciplinary group of physicians can determine whether this therapy is right for the patient.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.